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Hemoglobin (Hb)-based oxygen carriers (HBOCs) have been engineered to replace or aug-
ment the oxygen carrying capacity of erythrocytes. However, clinical results have generally
been disappointing, in part due to the intrinsic oxidative toxicity of Hb. The most common
HBOC starting material is adult human or bovine Hb. However, it has been suggested that
fetal Hb may offer advantages due to decreased oxidative reactivity. Large-scale manufac-
turing of HBOCwill likely and ultimately require recombinant sources of human proteins. We,
therefore, directly compared the functional properties and oxidative reactivity of recombi-
nant fetal (rHbF) and recombinant adult (rHbA) Hb. rHbA and rHbF produced similar yields
of purified functional protein. No differences were seen in the two proteins in: autoxidation
rate; the rate of hydrogen peroxide reaction; NO scavenging dioxygenase activity; and the
NO producing nitrite reductase activity. The rHbF protein was: less damaged by low lev-
els of hydrogen peroxide; less damaging when added to human umbilical vein endothelial
cells (HUVEC) in the ferric form; and had a slower rate of intrinsic heme loss. The rHbA
protein was: more readily reducible by plasma antioxidants such as ascorbate in both the
reactive ferryl and ferric states; less readily damaged by lipid peroxides; and less damag-
ing to phosphatidylcholine liposomes. In conclusion in terms of oxidative reactivity, there
are advantages and disadvantages to the use of rHbA or rHbF as the basis for an effective
HBOC.
Introduction
Globally, there is a need for a sustainable, long-lasting, artificial blood substitute due to increased demand,
the risk from new blood-borne diseases, difficulty in matching rare blood types, and religious aversion to
blood products [1]. There is also a growing realization that at a lower dose these products can facilitate
oxygen delivery to compromised tissue even in the presence of adequate numbers of red blood cells. In
these cases, the products are acting not as providers of oxygen, but as facilitators of oxygen transferred
from the red cells to the hypoxic tissue. These so-called ‘oxygen therapeutics’ have been suggested to be of
benefit in a variety of pathologies such as trauma, sickle cell disease, and subarachnoid hemorrhage [2].
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The use of the oxygen carrying hemoglobin (Hb) is favored as a starting material for such an extracellular oxygen
delivery product; consequently the field of Hb-based oxygen carriers (HBOCs) has resulted in a wide variety of pre-
clinical and clinical trials in this area, although with rather limited current success [3]. Traditionally, Hb is purified
from animal erythrocytes (including human), removing or reducing the stroma content; this Hb is then treated to
increase its size and vascular retention rate by cross-linking, polymerization, conjugation, or encapsulation [4]. Al-
though these approaches may increase protein stability, they also have the potential to increase product heterogeneity
and to alter reactivity [5].
The starting material for Hb production has varied. Bovine Hb has been used due to ease of production [6], sim-
ilar to human Hb and potentially favorable antioxidative properties [7]. Whereas marine worms produce large Hb
polymers (erythrocruorins) that have naturally evolved to function outside the cellular environment and hence can
be used as an HBOC without any post-purification modifications [8]. However, the most common animal source for
HBOC is human. Although historically outdated banked blood has been favored, recombinant techniques have also
been used [9]. Indeed it is hard to see how a bulk product such as HBOC could ultimately be produced worldwide
from discarded material from human blood banks, especially given the drive to decrease waste and hence the vol-
ume of outdated blood available as a source of Hb [10]. Recombinant human Hb has been produced in many species
including pigs [11], yeast [12], mice, and Escherichia coli [13-15]. Somatogen took HBOC product (rHb 1.0) made
from E. coli and produced human Hb in clinical trials [16].
Baxter Healthcare subsequently bought Somatogen ensuring a long-term production platform for its HBOC prod-
ucts combined with the additional flexibility of engineering favorable properties into the product [9]. The resultant
Baxter HBOC product (rHb2.0) entered clinical trials, but was discontinued due to adverse side reactions triggered
by extracellular Hb [9]. Extracellular Hb toxicity derives from a combination of nitric oxide scavenging reactions and
an intrinsic oxidative toxicity, which can lead to damage of cells, proteins, lipids, and DNA in the surrounding areas
[17]. Free heme released from unstable Hb molecules also has the potential to activate the immune system [18,19] by
acting as a damage-associated molecule pattern molecule (DAMP). Using recombinant tools, it is possible to design a
protein to be less oxidatively reactive [20]. It is also possible to engineer decreased nitric oxide scavenging properties,
decreasing the vasoconstriction produced by extracellular Hb [21]. However, these mutations can sometimes come
at the cost of a reduced Hb stability and an increased heme loss with associated toxic side effects [9,20], issues that
likely led to the discontinuation of rHb2.0.
HBOC products have largely focussed on using the adult HbA-based molecule. However, HbA is not the only form
of human Hb. Human Hb is a tetramer of homologous protein dimers of α- and β-type subunits. α-like genes are
encoded on chromosome 16 (α, ζ) and β-like genes on chromosome 11 (β, γ, δ, ε). During development, the Hb
tetramer changes from embryonic form of Hb to the fetal and then adult forms. The development lifetimes overlap,
but is broadly in the order: HbEGower-1 (ζ2ε2); HbE Portland-1 (ζ2γ2); HbEGower-2 (α2ε2); HbF (α2γ2); and HbA
(α2β2). These proteins have different functional properties suitable for their developmental roles.
The HbF molecule has recently proved to be of interest in HBOC design. Differences in the N-terminus between
theβ and γ subunits affect tetramer’s stability and gives HbF tetramers a 70-fold higher affinity compared with HbA,
increasing the tetramer/dimer ratio [22,23]. It has therefore been suggested that introducing mutations to make the
β subunit more like the γ subunit might be beneficial in the production of a recombinant HBOC; some success has
been achieved using this approach [14]. However, there is nothing more γ-like than the γ subunit itself. Therefore,
HbF makes a better starting material for HBOC production than HbA [24]. HbF might also benefit from a decrease
in Hb oxidative properties seen in recent studies [25,26]. However, matched against this is historical data suggesting
that HbF could be more pro-oxidative than HbA [27] and the emerging view that the oxidative properties of HbF are
implicated in damage in the maternal circulation in pre-eclampsia [28].
We therefore decided to do a detailed side-by-side comparison of the properties of HbF and HbA produced by
identical recombinant methods, focussing in particular on those reactions likely to be implicated in adverse side
reactions when these products are incorporated into an HBOC [3].
Methods
Protein expression and puriﬁcation
E. coli BL21 (DE3) cells transformed with pETDuet plasmid containing genes for the adult or fetal wild-type Hb
were grown in 2 l Erlenmeyer flasks containing 1.4 l growth medium at 37◦C, and agitated at 180 rpm until an OD600
∼2 was achieved. Hb expression was then induced by the addition of 0.5 mM IPTG, 0.25 mM ALA (aminolevulinic
acid), and 0.1 mM ferric citrate. Cultures were then bubbled with pure CO gas, flasks sealed thoroughly with rubber
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bungs, and grown for a further 18 h at 30◦C at 90 rpm. Cells were then harvested by centrifugation at 3500 g for 20
min at 4◦C.
Our previous rHb purificationmethodused cation exchange and size exclusionmethodology [29]. A small, variable
quantity contaminating protein ∼25 kDa was always found using this method. This has previously been attributed
to covalently linked dimers of β-Hb subunits [30]. The presence of only β subunits in our ∼25 kDa contaminant
was confirmed by MS, suggesting a similar assignment (data not shown). The addition of anion exchange and metal
affinity chromatography (details below) to the previous cation exchange resulted in almost complete removal of the
contaminant, resulting in>95% purity.
Cell pellets were resuspended in 10 mM sodium phosphate buffer, pH 6.0, before being lysed using an Avestin
C3 Emulsiflex homogenizer. The cell lysate was cleared by centrifugation at 38000 g for 30 min at 4◦C and the pH
was adjusted to 6.0 by the addition of small quantities of orthophosphoric acid. The centrifugation step was then re-
peated and the lysate filtered through a 0.45-μm syringe filter before being loaded on to a CM Sepharose column (GE
Healthcare) pre-equilibrated with 10 mM sodium phosphate buffer, pH 6.0. Hb was then eluted with a gradient of 70
mM sodium phosphate, pH 7.2. Selected fractions were then pooled and the volume decreased in a spin concentrator
and loaded on to a 5 ml Q-HP column (GE Healthcare) pre-equilibrated with 70 mM sodium phosphate buffer, pH
7.2. Protein was eluted with a 100 ml gradient of 50 mM sodium phosphate, pH 7.2, and 100 mM sodium chloride.
Fractions containing Hb were pooled and applied to a 5 ml HisTrap HP column (GE Healthcare) and eluted with a
100-ml gradient of 50 mM sodium phosphate, pH 7.2, 100 mM sodium chloride, and 100 mM imidazole. Finally, Hb
was concentrated using an Amicon Ultra 30000 MWCO (Millipore) and then buffer exchanged into 70 mM sodium
phosphate, pH 7.2. All buffers used during the purification procedure were bubbled with CO and the lysate and pro-
teins were bubbled with CO at every stage. Four to fifteen percent of gradient TGX stain free precast gels (Bio-Rad)
were used to assay purity following each column stage. The concentration of the ferrous CO (carbonmonoxyHb)
bound form of Hb was calculated using an extinction coefficient at 419 nm of 191000 M−1.cm−1 [31] and stored in
liquid nitrogen.
Optical spectroscopy
Unless stated otherwise, all optical spectra were taken using a Cary 5000 spectrophotometer (Agilent). To produce
the various different forms of Hb, the carbonmonoxyHb was first oxidized to the metHb (ferric Fe3+) form by the
addition of excess potassium ferricyanide, while under constant illumination under a strong but low temperature light
source that acts to photolyze the CO from the ferrous iron. The ferricyanide was then removed by gel filtration down
a PD-10 column (GE Healthcare). The deoxyHb form was made by addition of a slight excess of sodium dithionite
to the metHb form. This was then applied to a PD-10 column to generate oxyHb.
p50 measurements
The p50 measurements were carried out diluting concentrated stock Hb solutions in 100 mM HEPES buffer, pH 7.0,
100 mM sodium chloride, 1.2 mM sodium phosphate, and 1 mM EDTA. The final protein concentration was 100
μM. Before dilution, the samples were centrifuged to remove precipitates.
Oxygen equilibrium curves were measured at 25◦C, as previously reported [32]. For each sample, the absorption
spectrum (equilibrated in air) was collected immediately after thawing. The Hayashi enzymatic reducing system was
added to the solution before titrations to reduce metHb and to limit its formation during titration. Following, the
samples were deoxygenated using a helium flow and then equilibrated with different oxygen partial pressures.
Autoxidation
Autoxidation of 10μM oxyHb in 70mM sodiumphosphate buffer, pH 7.2, with 12.5mU superoxide dismutase (SOD)
and 10 nM catalase, at 37◦C, was monitored optically. The oxyHb concentrations were calculated using the extinction
coefficients of 125000 (415 nm) and 14600 (577 nm) using the unitsM−1.cm−1 [31]. Time courses (406–500 nm)were
fitted to single exponential function.
Heme release
ThemetHb (4μM) was incubatedwith hemopexin (4.5μM) obtained fromhuman plasma (Sigma) in 70mM sodium
phosphate buffer, pH 7.2, at 37◦C. The concentration of the metHb proteins were calculated optically using the ex-
tinction coefficient of 184000 M−1.cm−1 at 405 nm for the H2O bound high-spin form at pH ∼7. The time courses
(401–418 nm) were fitted to double exponential functions.
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Comparative analysis of oxidative hotspots in HbA and HbF using
quantitative proteomics
HbA and HbF proteins were treated with incremental doses (0, 5×, 10×) of H2O2 and incubated overnight in 20 mM
sodium phosphate buffer, pH 7.4 at 25◦C. All samples were processed and trypsinized using standard procedures.
LC-MS/MS analysis and targetted quantitative proteomics were utilized to identify and quantitate oxidative mod-
ifications in both Hb samples. All data were performed in triplicate on a Q-Exactive mass spectrometer (Thermo
Scientific) coupled to a Proxeon HPLC system. MS/MS spectra were initially searched against the human database
supplementedwith the above recombinant sequences using both Protalizer software (VulcanAnalytical) and theMas-
cot database search algorithm (Matrix Science) to confirm sequence identity and identify unmodified and oxidized
version of ‘hot spot’ peptides; all oxidized peptide reproducibly identified from database searches were then quanti-
tated. Extracted ion chromatograms (XICs) of modified (and unmodified) tryptic peptides were used to quantitate
oxidative differences. For relative quantitation, the ratio of each oxidized ‘hot spot’ peptide was calculated based on
the sum of the XIC peak area of all forms (oxidized and unmodified) to be 100%. Hotspot residues used for oxidative
comparisons included only conserved residues found on β and γ. All other ‘hotspot’ containing peptides identified
in the present study were consistent with previously published data.
Ferryl formation by reaction with peroxide
Varying concentrations of H2O2 were reacted with 10 μM metHb in a rapid mixing stopped-flow diode array spec-
trophotometer (Applied Photophyiscs) in 10 mM sodium phosphate buffer, pH 7.2 at 37◦C. For each concentration
of H2O2, three reactions were carried out, and the time courses generated averaged to a single rate trace and then
analyzed. The time courses (552–630 nm) were fitted to double exponential functions using the fitting program in-
corporated within the instrument. The contribution of the absorbance for both phases and for all the kinetic traces
generated was approximately the same. The two rate constants were then plotted against H2O2 concentration and
straight lines of best fit applied to the data points.
Ferryl reduction by ascorbate
MetHb (10 μM) in 70 mM sodium phosphate buffer, pH 7.2, was reacted with 30 μM H2O2 at 25◦C for ∼10 min to
produce ferrylHb (Fe4+). The reaction of metHb proteins with H2O2 was monitored optically to ensure 100% ferryl
formation. Trace catalase was added to remove excess H2O2 and this was incubated for a few seconds to fully react.
Sodium ascorbate was then added in a 1:1 volume ratio so that final concentration of Hb was 5 μM. The reactions
were then followed to completion, optically, using an Agilent 8453 diode array spectrophotometer. The time courses
(425–406 nm) were fitted to double exponential functions minimizing the least squares using Microsoft Excel Solver.
For each time course, the two calculated rate constants were assigned to the reactions of the α and β/γ subunits, and
the data plotted as a function of reductant concentration for each protein. This ascorbate concentration dependent
kinetic profile was fitted to a rectangular hyperbola plus a straight line (α subunits) or a single rectangular hyperbola
(β/γ subunits).
Ferric reduction by ascorbate
MetHb (20 μM) in 70 mM sodium phosphate buffer, pH 7.2, was reacted with a 1:1 volume ratio with sodium ascor-
bate at 25◦C so that the final concentration of Hb was 10 μM and ascorbate was 0.1 or 10 mM. The time courses
(577–630 nm) were fitted to a single exponential function.
Nitrite reductase
The proteinsweremade andmaintained in their deoxy states by addition of an excess of the reductant sodium dithion-
ite to metHb. DeoxyHb (10 μM) was reacted with sodium nitrite of varying concentrations in 70 mM sodium phos-
phate buffer, pH 7.2 at 24◦C. The reactions were monitored optically using an Agilent 8453 diode array spectropho-
tometer. The time courses (432–413 nm) were fitted to a single exponential function minimizing the least squares
using Microsoft Excel Solver. The data were plotted as a function of nitrite concentration for each protein and the
second order rate constants were determined by fitting to a straight line.
NO scavenging
An NO solution was prepared by dissolving the NO donor ProliNONOate (Cayman Chemical Company) in 25 mM
NaOH. The concentration of ProliNONOate was determined using an extinction coefficient of 8500 M−1.cm−1 at
250 nm (when added to the buffer at neutral pH, 1.8 molecules of NO are released per ProliNONOate molecule). The
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ProliNONOate was then diluted into thoroughly degassed 70 mM sodium phosphate buffer, pH 7.2. 10 μM oxyHb
was reacted 1:1 with varying concentrations of ProliNONOate in a rapid mixing stopped-flow spectrophotometer
(Applied Photophyiscs). Due to the speed of the reaction, the temperature was set to 15◦C. Reactions were monitored
at 422 nm and fitted to a single exponential. The data were plotted as a function of NO concentration for each protein
and the second order rate constants were determined by fitting to a straight line.
Lipid oxidation
α-phosphatidylcholine (5 mg/ml) derived from soybean (Type II-S, Sigma) in 10 mM sodium phosphate buffer, pH
7.2, was sonicated in a water bath for ∼5 min until no particulates could be seen. To produce unilamellar liposomes
of uniform diameter, this suspension was then passed through a Northern Lipids liposome extruder containing a
membrane with size cutoff 100 nm (Whatman) for a minimum of ten times. Liposomes were stored at 4◦C and used
within 4 h.
MetHb or oxyHb (2 μM) was incubated with 200 μg/ml liposomes, for 10 h at 25◦C. Sodium ascorbate was added
at a final concentration of 50 μM as indicated. Lipid oxidation was monitored by following the production of conju-
gated dienes using a Tecan Infinite M200Pro plate reader. The time courses (234–650 nm) were plotted and used to
determine the lag time before the onset of lipid oxidation.
Reactions with 13S-hydroperoxy-9Z,11E-octadecadienoic acid
The lipid hydroperoxide 13S-hydroperoxy-9Z,11E-octadecadienoic acid (HPODE) was produced as previously de-
scribed [33]. HPODE (50 μM) was reacted with 3.7 μM metHb in a rapid mixing stopped-flow spectrophotometer
(Applied Photophyiscs) in 50 mM sodium phosphate buffer, pH 7.2 at 37◦C in the presence or absence of 50 μM
ascorbate. With the instrument in the photomultiplier/monochromator set up, heme bleaching was monitored using
a single wavelength at 405 nm. The rate traces were fitted to a double exponential function (the amplitudes of the two
phases were constrained to be equal) using the fitting program incorporated within the instrument.
Primary cell culture, treatment, and assays
Human umbilical vein endothelial cells (HUVECs), a primary cell line, was obtained from Lonza. Cells were main-
tained in complete primary cell EGM medium (Lonza) in a humidified atmosphere with 5% CO2 at 37◦C until seven
passages were reached. For experiments to test the effect of rHb on cells, cells were trypsinized, counted, plated into
24-well plates and maintained until 70% confluent.
Prior to all treatments, cells were gently washed with warm PBS and the medium was replaced by serum and
phenol-free EGM medium for HUVECs. Cells were treated by adding either 50 μM Hb (recombinant adult Hb
(rHbA) and recombinant fetal Hb (rHbF) in oxy or met forms), 50 μM ascorbate, or 10 mU/ml glucose/glucose
oxidase system (GOX) to the medium in the total volume of 250 μl. Cells were placed back into the incubator and
harvested after either 4 or 24 h as indicated. All experimental conditions were performed in four replicates.
MetHb proteins were prepared as previously stated. The highly concentrated oxyHb proteins required for addition
to the cells were prepared by incubating carbonmonoxyHb under bright constant illumination while gently blowing
a stream of pure oxygen over the surface of the liquid, on ice. Conversion into oxyHb form was monitored spectrally
and was completed by ∼30–45 min.
Cellular damage was assessed by measuring levels of lactate dehydrogenase (LDH) released into cellular medium.
The LDH assay (Sigma–Aldrich) was performed after 24 h of exposure to the experimental treatment according to
manufacturer’s instructions. The absorbance at twowavelengths (450 and 650nm)was obtained using a Tecan Infinite
M200Pro plate reader and both values were used to calculate levels of LDH.
The cellular response to oxidative stress in treated cells was evaluated by activity of SOD. The SOD assay (Sod
OxySelect superoxide dismutase activity assay kit (Cell Biolabs Inc.)) was performed according to manufacturer’s
instructions 4 h post treatment on lysed cells. The absorbance values at 490 and 650 nm were taken and the level of
SOD activity calculated.
Statistics
HbA was compared with HbF under the same experimental conditions. Data are presented as either mean and SD of
n replicate experiments (statistical significance determined via the Student’s t test) or mean and S.E.M. derived from
non-linear curve fitting of n points in Kaleidagraph version 4.5.2 (statistical significance determined via the lack of
overlap of 95% confidence intervals of means). The specific test used for each measurement is indicated in Table 1
and/or in the relevant figure legend.
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Table 1 Differences between rHbA and rHbF
Statistically signiﬁcant results comparing HbA with HbF are highlighted in gray. Data are presented as either mean +− S.D. of n replicate experiments
(statistical signiﬁcance determined via the Student’s t-test) or the mean +− S.E.M. derived from curve ﬁtting of n points (statistical signiﬁcance determined
via the overlap or not of 95% conﬁdence intervals of the means). Yield is calculated as milligrams of puriﬁed protein per liter of bacterial culture; for p50
results, h indicates the Hill coefﬁcient; for lipid oxidation and HPODE damage results −/+ asc indicates −/+ 50 μM ascorbate.
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Results
The results of all experiments performed to compare rHbA and rHbF are summarized in Table 1. All protein con-
centrations are given in μM of the total heme present.
Yield
rHbA and rHbF were expressed and purified as described in ‘Methods’ section. Gel electrophoresis was used to con-
firm purity of Hb (Supplementary Figure S1). The HPLC of the two recombinant proteins (Supplementary Figure
S2) shows that no significant amount of protoporphyrin-IX was present as can occur with lack of iron. We did not
observe any statistical differences in the yields between rHbA and rHbF (Table 1). However, there was considerable
variability in batch to batch yield, particularly for rHbF.
Oxygen binding
Oxygen binding curves were measured for our preparations of rHbA and rHbF. Analysis of these curves allowed
calculation of the p50 and Hill coefficient values [32]. Our results showed that both rHbA and rHbF can bind oxygen
in a co-operativemanner but that rHbF has a slightly lower affinity and slightly higher co-operativity (Hill coefficient)
compared with rHbA (Table 1 and Supplementary Figure S3). Upon PEGylation the p50 and Hill coefficients of both
proteins decreased, butmore so for rHbF resulting in a relatively high affinity but low co-operativity for the PEGylated
product.
Autoxidation and heme loss
The autoxidation of HbA and HbF was measured at 37◦C for a 3-h period in the presence of SOD and catalase.
The time course (406–500 nm) was fitted to a single exponential; the rates of autoxidation of rHbA and rHbF were
not significantly different (Table 1). Heme loss from the met form of rHbA and rHbF was measured at 37◦C for a
10-h period. The resulting kinetic traces (401–418 nm) could be fitted to a double exponential function with the two
rates attributed to either the α/β or α/γ subunits for rHbA and rHbF, respectively. The slower rate of heme loss in
rHbA was assigned to the α subunit and the faster rate to the β subunit as determined from previous studies of heme
dissociation kinetics [34-36]. The slower of the two rates was not statistically different between rHbA and rHbF and
therefore the slower rate of heme loss in rHbF was also assigned to theα subunit. In contrast, the faster rates for rHbA
and rHbF, assigned to the β and γ subunits respectively, were significantly different; slower for rHbF compared with
rHbA (Table 1).
Ferryl formation and reduction
The rates of ferryl formation of rHbA and rHbF were measured via the reactions of the ferric Hb with hydrogen per-
oxide. On rapid mixing of peroxide with metHb forms of rHbA and rHbF spectral changes were observed consistent
with the conversion of the metHb into the ferrylHb forms (Figure 1A). The kinetic traces for the reaction (552–630
nm) confirmed that the ferryl species was fully formed at all the peroxide concentrations used (Figure 1B). The time
courses were fitted to a double exponential function and the rates attributed to the α subunits (slower rate) or β/γ
subunits (faster rate) and plotted against peroxide concentration (Figure 1C). These data showed a linear dependence
on the concentration of H2O2 and the second-order rate constants for the conversion of metHb into ferrylHb were
calculated (Table 1). There was no difference observed between adult and fetal Hb fast rates (β/γ subunits), and while
there is a small statistical difference in the slow rates (α subunits) it is not likely to be meaningful.
The ferryl reduction kinetics of rHbA and rHbF were compared in the presence of differing concentrations of
ascorbate. The time courses for the reduction were fitted to double exponential functions and the two rates assigned
to the α or β/γ subunits of rHb. There was a slight decrease in the autoreduction rate for rHbF compared with rHbA
(Table 1). The kinetics of ferrylHb reduction as a function of ascorbate concentration are presented in Figure 2. The
faster rate constant (α subunit) could be best fitted to a rectangular hyperbola plus a straight line, as the second
phase of the curve did not conform to a hyperbolic function. These two phases correspond to direct reduction of the
heme (low affinity) and electron transfer via surface exposed tyrosine residues (high affinity) [29]. The slower rate
constant (β/γ subunit) only had a single slow phase, corresponding to the low affinity pathway, and was fit to a single
rectangular hyperbola. The values for both the high and low affinity pathways for the α subunits of rHbA and rHbF
are comparable (Table 1). The values for the low affinity pathway for theβ/γ subunits are different. rHbF has 1.5-times
higher Vmax than rHbA. However, this is offset by a four times higher KM, meaning that at low (physiological) levels
of ascorbate the ferryl iron in the β subunit is more readily reduced by ascorbate than ferryl iron in the γ subunit.
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 1. Rates of ferryl formation measured by the reaction of H2O2 with the met forms of rHbA and rHbF
The met forms of rHbA and rHbF (10 μM) were reacted with varying amounts of H2O2 in 20 mM sodium phosphate buffer, pH 7.2
at 37◦C. (A) The spectral changes observed in the visible region for the conversion of met rHbF into the ferryl form on reaction
with 1 mM H2O2. Spectra are shown every ∼1 s of the reaction from t = 0 to 20 s. (B) A typical kinetic trace for the conversion of
met rHbA into the ferryl form on reaction with 1 mM H2O2. (C). The observed rate constants for the reactions of rHbA and rHbF
with varying concentrations of H2O2. For rHbA and rHbF, the kobs.s−1 value was calculated by fitting the kinetic traces to double
exponential functions. Triangles = rHbA (open = fast, closed = slow), circles = rHbF (open = fast, closed = slow). Straight lines of
best fit have been applied to the datasets.
Ferric reduction
The ferric reduction kinetics of rHbA and rHbF were measured by reaction of metHb to oxyHb with high and low
ascorbate concentrations. Spectral changeswere observed consistentwith the conversion of themetHb into the oxyHb
forms (Figure 3A). The time courses (577–630 nm) were fitted to a single exponential function and at both ascorbate
concentrations used rHbA had a greatly increased rate of ferric reduction compared with rHbF (Figure 3B and Table
1).
Nitrite reductase
The nitrite reductase activities of rHbA and rHbFwere compared bymeasuring the reaction of deoxyHb with sodium
nitrite. The resulting kinetic traces (432–413 nm) were fitted to a single exponential and plotted against nitrite con-
centration (Figure 4). These data were fit to a straight line; the second order rate constants for rHbA and rHbF were
not statistically different (Table 1).
Nitric oxide dioxygenase (NO scavenging)
The NO dioxygenase activity of rHbA and rHbF was compared bymeasuring the conversion of oxyHb into metHb at
varying concentrations of NO. The resulting kinetic traces (422 nm) were fitted to a single exponential function and
8 c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 2. Dependence of the rate constants for ferryl Hb reduction on ascorbate concentration for adult and fetal Hb
Ferryl Hb (10 μM) was reacted with ascorbate in 70 mM sodium phosphate buffer, pH 7.2 and rate constants for the two phases
of ferryl reduction were determined by fitting to a double exponential function. (A) rHbA and (B) rHbF. Closed symbols represent
α subunit (the rate constants were fitted to a rectangular hyperbola plus a straight line function (solid lines)), and open symbols
represent β/γ subunit (fitted to a rectangular hyperbola (solid lines)).
Table 2 H2O2 induced tri-oxidation of C93 and C104 of rHbA and rHbF
H2O2:Hb rHbA βC93 rHbF γC93 rHbA αC104 rHbF αC104
0 3.17 +− 0.22% 6.3 +− 0.81% 1.9 +− 0.79% 0.8 +− 0.21%
5:1 21.5 +− 1.48% 20.9 +− 0.38% 1.1 +− 0.17% 1.28 +− 0.16%
10:1 29.7 +− 0.25% 28.9 +− 0.79% 1.1 +− 0.07% 2.3 +− 0.15%
Data are presented as mean +− S.D. of n=3 replicate experiments.
plotted against NO concentration (Figure 5). These data were fitted to a straight line; the second order rate constants
for rHbA and rHbF were not statistically different (Table 1).
Comparative analysis of oxidative hotspots in HbA and HbF using
quantitative proteomics
Experimental oxidative conditions were performed to test the role H2O2 has on the observed post-translational ox-
idation of oxidative hotspots in recombinant HbA and HbF. Toward this goal, we utilized quantitative MS to target
all peptide charge states. XICs were generated from the most abundant monoisotopic peak of each peptide isotopic
profile and the resulting ratio differences were compared for oxidized and unoxidized hotspot peptides.
As purified (Table 2) β/γ C93 tri-oxidation of HbF was slightly higher than HbA (6.3% compared with 3.17%). In
both cases, the extent of oxidation correlated with incremental H2O2 increases. For example, 10× H2O2 resulted in
nearly a ten-fold higher ratio for HbA C93 oxidation and five-fold higher ratio for HbF compared with the control
where no peroxide was added. The data in Table 2 also show tri-oxidation of αC104. For both proteins, α104 cysteic
acid oxidation levels were at consistently lower levels than β/γ C93 tri-oxidation; rHbA showing higher oxidation
than rHbF at baseline, but appearing more resistant to added peroxide.
Oxidative damage to lipids and primary cells
Liposome reactions
The lipid oxidation of the metHb and oxyHb forms of rHbA and rHbF with and without reductant was compared
(Figure 6). In the absence of reductant, the lag phase of the met form of rHbF was significantly shorter than that of
rHbA. When reductant was added (50 μM ascorbate) the lag times greatly increased but the lag time of rHbF was still
shorter than rHbA (Table 1 and Figure 6A). Similarly for the oxyHb form rHbF had statistically significantly shorter
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 3. Ferric reduction by ascorbate for adult and fetal Hb
Ferric (met) Hb (10 μM) was reacted with ascorbate in 70 mM sodium phosphate buffer, pH 7.2 and reduction of metHb to oxyHb
monitored optically and rate constants were determined by fitting to a single exponential function. (A) Example of absorbance
spectra under conditions indicated. (B) Rates of ferric reduction at high and low concentrations of ascorbate for A1 (dark gray) and
F1 (light gray).
lag times. In the presence of reductant, the lag times did not increase as dramatically for the oxyHb form as for the
metHb form but rHbF still produced shorter lag times (Table 1 and Figure 6B).
HPODE reactions
Figure 7 shows the reactions of the metHb forms of rHbA and rHbF at a fixed concentration of 50 μM of the lipid
peroxide HPODE in the absence or presence of reductant. The time course of heme bleaching was fitted to a double
exponential function. Both in the absence and presence of reductant the fast rates for rHbF were found to be signifi-
cantly faster than rHbA. The difference between the slow rates however was found to be not statistically significant.
Addition of the reductant (ascorbate) resulted in a minor decrease in the reactivity of both proteins with HPODE.
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Figure 4. Nitrite reductase activity of adult and fetal Hb
DeoxyHb (10 μM) was reacted with sodium nitrite in 70 mM sodium phosphate buffer, pH 7.2. Rate constants were determined by
fitting to a single exponential function and were plotted against nitrite concentration. The second order rate constants were then
determined by fitting to a straight line (filled circles represent rHbA and open squares rHbF).
Figure 5. NO scavenging activity of adult and fetal Hb
OxyHb (5 μM) was reacted with NO in 70 mM sodium phosphate buffer, pH 7.2 at 15◦C. Rate constants were determined by fitting
to a single exponential function and were plotted against NO concentration. The second order rate constants were then determined
by fitting to a straight line (filled circles represent rHbA and open squares rHbF).
Primary cells
Cell viability due to cellular membrane damage wasmeasured (24 h post treatment) by LDH release, while short term
(4 h post treatment) oxidative stress was measured by SOD induction. Hydrogen peroxide addition (via a GOX) was
used as a positive control and caused significant increases in both assays (Figure 8). Varying the concentration of rHb
established that a 50 μM concentration was optimally sensitive in our assays (data not shown).
Different redox states of rHbA and rHbF were then tested. Figure 8 shows the cytotoxic effects of rHbA and rHbF
in combination with 10 mU GOX and 50 μM ascorbate (as indicated) on HUVECs. The cells were lysed after 4 h
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 6. Lipid oxidation lag times for rHbA and rHbF
rHb (2 μM) was reacted with liposomes in 70 mM sodium phosphate buffer, pH 7.2, +−50 μM ascorbate, and production of conju-
gated diene formation was measured via absorbance at 234 nm. The lag time before oxidation was calculated. (A) MetHb and (B)
oxyHb. rHbA circles, rHbF triangles, open symbols without reductant, filled symbols with 50 μM ascorbate. Values are the mean
from three measurements and error bars represent S.D. from the mean.
Figure 7. The reactions of the met forms of rHbA and rHbF with HPODE, in the absence and presence of the physiological
reductant ascorbate
HPODE (50 μM) was reacted with 3.7 μM metHb in a rapid mixing stopped-flow spectrophotometer in 50 mM sodium phosphate
buffer, pH 7.2 at 37◦C +− 50 μM ascorbate. Rate traces showing heme bleaching over time measured at 405 nm.
for the SOD assay and the cellular medium was taken for the LDH assay 24 h post treatment. There was increased
oxidative stress and membrane damage following the addition of adult and fetal rHb compared with control cells (sig-
nificance indicated in Figure 8). In general, combination rHb with GOX increased the cytotoxic damage, compared
with treatment with Hb alone, whereas, addition of 50 μM ascorbate to the cellular medium rescued the cytotoxicity
of rHb, but not to the level of control cells. In general, there were no significant differences between rHbA and rHbF
in the majority of the treatments (Supplementary Table S1). However, rHbA did show a somewhat larger increase in
both SOD induction and LDH release when met and oxy forms were added to cells in the presence of GOX alone.
12 c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
Bioscience Reports (2018) 38 BSR20180370
https://doi.org/10.1042/BSR20180370
Figure 8. The effects of adding rHbA (A) and rHbF (F) to HUVECs
HUVECswere incubated in serum and phenol-free EGMmedium containing either 10mM sodium phosphate buffer, pH 7.2 (control),
10 mU/ml GOX or 50 μM rHbA and rHbF metHb (A,C) and oxyHb (B,D) in the absence or presence of reductant (ascorbate). For
the SOD assay (A,B), cells were lysed 4 h post treatment. Cellular medium was used for LDH assay (C,D) 24 h post treatment. Each
bar represents mean +− S.D. of four experimental repeats. Statistical differences between control and treatment conditions were
analyzed using unpaired Student’s t test and are presented as * where *P<0.05, **<0.01, ***<0.001. Statistical differences between
rHbA and rHbF under each condition are presented in Supplementary Table S1; # represents P<0.05.
Discussion
Our detailed comparison of rHbA and rHbF revealed some differences that could affect their ability to be an effective
component of an HBOC.
Preparation and oxygen-binding properties
Using our expression system we were able to produce similar yields of adult and fetal Hb in shake flasks, not incon-
sistent with historical studies [37]. However, in order to manufacture Hb in large enough quantities for an HBOC,
production would need to shift to large-scale fermentation. This has been achieved for HbA [38,39], but not yet for
HbF.
In vivo, HbF has a higher oxygen affinity than HbA in order to enable the fetus to capture oxygen from the mater-
nal circulation. However, in contrast with some organisms, in humans this difference is not an intrinsic property of
the functional tetramer, but instead by a well-characterized modulation of the binding of the physiological effector
molecule bisphosphoglycerate (BPG) [40]. This is therefore less likely to be relevant when Hb is used outside the red
blood cell as an HBOC. Consistent with this and previous studies [37], we observed only a small difference between
the two proteins under ‘pseudo-physiological’ conditions intended to mimic plasma rather than red blood cells (pH
7.0, 100 mM sodium chloride, 1.2 mM sodium phosphate). Any small ‘intrinsic’ oxygen p50 differences between the
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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use of the γ and β subunit is anyway likely to be only minor compared with subsequent treatments of the protein. To
form a viable HBOC, Hb needs to be modified to remain longer in the vasculature and these treatments have signif-
icant effects on the oxygen affinity. In the present study, we used the EURO-PEG-Hb method that aims to preserve
a more normal oxygen affinity by PEGylating the protein in the deoxy T state [41]. In this case, we did see more
significant differences between the proteins. Following EURO-PEG PEGylation protocol, fetal Hb had a higher oxy-
gen affinity than the adult protein and lacked co-operative oxygen binding (Supplementary Figure S3). This higher
oxygen affinity for PEGylated fetal Hb is not necessarily a bad property. Sangart have previously championed MP4
(Hemospan) – a high affinity Hb with no co-operative oxygen binding – as oxygen therapeutic. However, the p50 for
EURO-PEG-HbF is even lower than the 5 Torr for MP4, making it only able to deliver oxygen to the most hypoxic
tissues. Therefore, the addition of mutations to raise the p50 might be necessary.
Protein stability – autoxidation, heme loss, and heme reduction
Outside the red blood cell, oxyHb is oxidized easily to metHb which is physiologically inactive [42]. MetHb is also
far more likely to lose its heme cofactor than oxyHb [36]. Given the ferric:superoxide (Fe3+−O2•−) nature of the
iron-oxygen bond in oxyHb, all else being equal, one might expect the oxygen affinity to vary inversely with the rate
of autoxidation in globins with very high oxygen binding affinity corresponding to low autoxidation. This relationship
does indeed hold for a variety of mutations in the myoglobin heme pocket that stabilize or destabilize the Fe3+−O2•−
bond; mutations that stabilize the bond increase oxygen affinity and decrease autoxidation [43]. Intriguingly, the op-
posite relationship (a linear correlation between oxygen affinity and autoxidation) exists if the heme group itself is
modified to shift the resonance state between Fe2+−O2 and Fe3+−O2•−. A heme modification that shifts the reso-
nance toward the Fe2+−O2 form results in an increase in both the O2 affinity and a decrease in autoxidation [44].
Understanding (and potentially decreasing) the autoxidation rate is therefore an important factor in HBOC design
as it can impact both oxygen affinity and oxidatively damaging properties. In this context, we found that rHbA and
rHbF had the same intrinsic rate of autoxidation, mirroring their very similar oxygen affinities.
The rate of heme release [36] from Hb is a major consideration while making an HBOC. Heme can trigger oxida-
tive reactivity itself, but perhaps more importantly acts as a DAMP molecule activating Toll-like receptor 4 (TLR4)
of the innate immune system leading to oxidant production, inflammation, and vascular injury. High amounts of
autoxidation and free heme release from the recombinant protein rHb3011 likely led to the failure of HBOC derived
from it in clinical trials [9]. Heme is preferentially released from the ferric (met) form of Hb. Perhaps unsurprisingly
our results indicated that the α subunits of both proteins have the same rate of heme release from the ferric state.
However, the slower rate of heme release from the γ subunits compared with theβ indicates that in this respect rHbF
is more stable than rHbA.
Outside the cell, the dominant reaction regenerating oxyHb frommetHb is the non-enzymatic reduction by plasma
ascorbate [45]. Reduction of metHb by ascorbate is known to occur via preferential reaction of the β subunits [46].
Our results with rHbF show that the same is not true for the γ subunit with the rate of reduction in γ being as slow as
the α subunit. Therefore, rHbF reduction frommetHb to oxyHb is very slow in comparison with rHbA even at high
ascorbate concentrations.
In summary, both proteins have advantages and disadvantages. The oxy forms autoxidize at a similar rate. The
resultant metHb is more readily reduced back to oxyHb for the adult protein. However, as long as it remains in the
ferric state, the adult protein is more likely to lose its heme cofactor.
Formation and reduction of ferryl heme
Once autoxidized to Fe3+, the resultant metHb can be further oxidized by peroxide(s) to the Fe4+ ferryl species. Lack-
ing protective catalase, in the plasma levels of peroxide can increase under stress conditions such as tissue injury;
therefore, extracellular Hb is potentially more susceptible to damage by peroxide and ferryl formation. The ferryl
Hb species is known to be damaging in vivo [3,47], generating lipid oxidation products such as 4-hydroxynonenal
and isoprostanes, both biomarkers of oxidative stress and in the case of isoprostanes, potent vasoactive compounds
[48,49]. It would be a desired property of any potential blood substitute to have either a slow rate of ferryl formation
or once ferryl is formed, for it to be quickly converted into the less damaging ferric form. Our comparison of the
recombinant proteins found no statistical differences in the rates of ferryl formation by reaction with peroxide. This
is in contrast with that shown for native Hb where the HbF γ chain was oxidized at a slightly higher rate than HbA
β chain [26].
Once ferryl Hb has been formed, the ferryl heme can be reduced to the met form by a range of compounds and
reductants [29,33,50,51]. It has previously been shown that this occurs via two distinct pathways of electron transfer
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from the reductant to the heme iron: direct reduction of the heme (low affinity) and electron transfer via surface
exposed tyrosine residues (high affinity) [29,47,52]. Our comparison of rHbA and rHbF found no difference in re-
duction in the α subunits via the high or low affinity pathways. However, the KM for the low affinity pathway of the
β/γ subunits was four times higher for fetal than adult meaning rHbF is less able to remove ferryl Hb via reduction
by ascorbate. As it is possible to engineer increases in this rate as desired by the insertion of redox active tyrosine
residues into the β subunit [29,47,50] in adult proteins, it is likely a similar effect could be engineered into the γ
subunit to overcome this deficit.
Nitric oxide reactivity
The NO dioxygenase activity of oxyHb (oxidation to met) means that cell-free Hb rapidly scavenges NO, causing
vasoconstriction and an increase in blood pressure [21,53].Our results showed no difference in adult and fetal HbNO
oxidation. Mutations to introduce bulky amino acid residues to limit ligand entry into the pocket have produced Hb
molecules with lower NO scavenging and blood pressure effects [9]. There is no reason to suppose that homologous
mutations in fetal Hb would not have the same effect.
Nitrite reduction by deoxyHb generates NO, initially binding to deoxyHb but eventually being released as NO gas
resulting in vasodilation [54-56]. Thus the nitrite reductase activity of Hb has been suggested to be a useful property
for an HBOC to possess, overcoming the decrease in NO levels caused by the oxidation reaction [57]. Indeed nitrite is
sometimes added following HBOC addition, though with varying levels of success [58]. We saw no difference in the
rate of nitrite reduction of deoxyHb between the recombinant adult and fetal proteins in the absence of oxygen (hence
with Hb in the T state). This is perhaps somewhat surprising given the faster reactivity seen in the reaction of native
T state fetal compared with adult ovine Hb [59]. However, as the fastest – and more likely physiologically relevant
reactions are seen in the R state protein [60,61] – the lack of a difference here may not have relevant consequences
for HBOC design.
Ease of oxidation of amino acid subunits
Previously it has been shown that βC93 is the prominent end point for free radical induced protein oxidation; oxida-
tion at other residues (β,γ, orα) is usually lower [62]. Our data agree that theα subunit is more resistant to oxidation
and therefore more oxidatively stable in the Hb tetramer. The γ chain appeared somewhat more resistant than the β
chain as in the absence of added peroxide rHbF showed less oxidation than rHbA. However, both proteins responded
to incremental increases in peroxide in a similar manner and at higher peroxide this fetal/adult difference disap-
peared, suggesting the proteins are broadly equivalent in terms of oxidative stability. In our recombinant proteins, we
did not see the dramatic preferential increase in stability for native fetal Hb compared with native adult Hb observed
previously [26]. It is unclear whether this difference is a fundamental feature of native compared with recombinantly
produced proteins or instead due to differences in the purification methods used. On the one hand, it is sometimes
difficult to remove contaminating antioxidant proteins (catalase/SOD) from Hb purified from red blood cells and on
the other hand oxidation can more readily occur in the production and purification of recombinant proteins. Either
effect could cause the experimental differences observed between the present paper and previous studies [26].
Oxidative damage to lipids
It is not clear what implication differences in amino acid oxidizability have for HBOC. The amino acids in fetal Hb
seem less likely to be oxidized by peroxide; yet fetal Hb reacts as fast with peroxide and the ferryl and ferric states
are less readily detoxified by reductants. Oxidants have to go somewhere; it could be argued that, in sacrificing its
own amino acids and heme, the adult protein is less likely to damage external biomolecules. On the other hand, the
features of fetal Hb (decreased Hb amino acid oxidation and decreased reactivity to reductants) mirror the effects of
adding haptoglobin to Hb which is known to protect against Hb-induced oxidative damage such as lipid oxidation
[63]. We therefore tested directly the ability of rHbA and rHbF to react with external oxidized external lipid and lipid
peroxides. We found clear differences between the oxidative properties of rHbA and rHbF indicating that rHbF is
more oxidatively damaging than rHbA at least with regard to lipid damage.
Liposome reactions
These experiments used liposomes formed from phosphatidylcholine, containing small amounts of lipid hydroper-
oxides, which react with hemoproteins as described previously [47]. The lipid oxidation reaction is initially slow,
producing a lag phase before ferryl Hb and radical concentrations reach a critical level and a cascade of lipid oxida-
tion starts. Therefore, the longer the lag phase, the less damaging the Hb. Under all conditions tested rHbF was found
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to be more damaging than rHbA. When reductant (ascorbate) was added to the assay the lag times increased for both
rHbA and rHbF but less so for rHbF for both met and oxy Hb. This is consistent with our other data showing the
oxidiz ed forms of rHbF being less readily reducible than the adult protein.
HPODE reactions
The reaction of Hb with the lipid peroxide HPODE is a complex one that leads to degradation of the heme and
destruction of conjugated dienes of the lipid [64]. Our experiments monitoring heme bleaching followed a similar
pattern to our data on lipid oxidation. Again, rHbF was more aggressive suggesting it has the potential to be more
damaging in an environment containing lipids.
Oxidative damage to primary cell lines
Cytotoxicity of extracellular Hb molecule through its redox cycling reactions and generation of reactive oxidative
species is well documented [65,66]. HUVECs were treated with rHbA and rHbF (oxyHb and metHb). General levels
of cellular damage were measured by LDH release and oxidative stress was monitored by the induction of the defence
protein SOD.
The addition of 10 mU GOX to cellular medium generates H2O2, a potent oxidizing agent that creates substantial
oxidative stress [67]. This positive control increased both LDH release and SOD induction. The met forms of the
recombinant proteins induced oxidative stress, but did not increase overall cellular damage. In contrast, the oxy forms
increased both oxidative stress and cellular damage, suggesting that the superoxide produced during the autoxidation
process was a significant contributory factor in the heme-induced damage.
The combined Hb and GOX treatment data showed increased cellular damage and oxidative stress compared with
rHb only, but decreased or similar damage comparedwithGOX alone, i.e. the effects ofGOX and rHb are not additive
in this system. This reflects the ‘Janus face’ of Hb interactions with added peroxide in cellular systems. Hb acts as a
peroxidase via the formation of intermediate ferryl iron and protein bound free radicals [47]. In certain cases Hb can
exacerbate GOX induced cellular damage due to the reactivity of these oxidizing species [7], but in others damage
can actually decrease if these Hb ferryl and radical species are less reactive than other cellular targets of peroxide [68].
This protective effect is seen most clearly when Hb is added to peroxide-treated cells in the presence of haptoglobin
as haptoglobin binds tightly to Hb decreasing its oxidative reactivity, without diminishing its peroxidase activity [63],
in effect acting as a ‘safe’ peroxide removal mechanism. Reductants can also modulate Hb oxidative cytotoxicity.
Physiological levels of ascorbate in the plasma, typically in the range of 50 μM, added to cellular medium reduced
the cytotoxic damage from both rHb (adult and fetal) with or without the addition of GOX, in line with previous
investigations [69,70].
A direct-paired comparison (Supplementary Table S1) revealed very few significant differences between adult and
fetal rHb. Where a difference was found, rHbF was found to be less cytotoxic than rHbA. The reactivity of fetal and
adult Hb seem to vary with the assay system. In cells (the present paper) and when added to DNA [25], fetal Hb
seems somewhat less damaging. However, when added to lipids (the present paper), reverse is the case and fetal Hb
is a more aggressive oxidant.
Conclusion
Recombinant human adult and fetal Hb are both suitable starting materials for producing a HBOC. While the core
reactivity or rHbA and rHbF differ, the direction of difference is sometimes in favor of fetal and sometimes in favor
of adult. In most cases, additional mutations and/or the subsequent treatment of the protein to enhance vascular
lifetime (PEGylation, cross-linking, encapsulation) will likely have a larger effect than the original difference between
the β and γ chains.
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